NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 9.99% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 8.39% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.45% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.72% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.99% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.49% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.25% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.98% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.73% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.68% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.64% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.60% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.53% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.49% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.28% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.27% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.25% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.24% |